We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in Store for Leidos Holdings (LDOS) in Q4 Earnings?
Read MoreHide Full Article
Leidos Holdings, Inc. (LDOS - Free Report) is scheduled to release fourth-quarter and 2019 results on Feb 18, after market close. In the last reported quarter, the company delivered a positive earnings surprise of 13.33%.
Moreover, Leidos Holdings has a four-quarter positive earnings surprise of 8.93% on average.
Let’s discuss the factors that are likely to get reflected in the upcoming quarterly results.
Factors to Consider
Leidos Holdings generates almost half of its revenues from the Defense Solutions segment. The current U.S. administration is in favor of spending abundantly on the nation’s defense. As a result, steady order growth from Pentagon and other U.S. allies are expected to have boosted defense revenues for the company.
In Health segment, Leidos Holdings completed the acquisition of IMX Medical Management Services and its affiliated businesses in the third quarter. Positive synergies from this buyout are expected to have bolstered the company’s fourth-quarter performance.
Moreover, during the fourth quarter, Leidos Holdings completed the Department of Defense (DoD) Healthcare Management Systems Modernization program (DHMSM), the largest IT transformation in the history of the military health system. Further, the company started deployment of MHS Genesis, a new electronic health record for the Military Health System since Sep 7, 2019.
Such developments must have boosted new program revenues for the company in the yet-to-be-reported quarter. Considering the aforementioned factors, we remain optimistic about Leidos Holdings’ top and bottom line performances in the fourth quarter.
Notably, the Zacks Consensus Estimate for fourth-quarter revenues is pegged at $2.83 billion, which indicates a rise of 6.9% from the year-ago quarter’s reported figure.
Such solid revenue growth along with expected segmental operating margin growth might have boosted the bottom line. The Zacks Consensus Estimate for fourth-quarter earnings per share is pegged at $1.35, which indicates rise of 22.7% from the year-ago quarter’s reported figure.
During the fourth quarter, Leidos Holdings signed a few strategic agreements with the likes of Clarify Health Solutions, D.C. United and Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network. We may expect further details on these deals and their respective impact, if any, once the company releases its numbers on Feb 18.
Earning Whispers
Our proven model does not conclusively predict an earnings beat for Leidos Holdings this earnings season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat.
Earnings ESP: The company’s Earnings ESP is 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Raytheon Company reported fourth-quarter 2019 earnings per share (EPS) of $3.16 from continuing operations, outpacing the Zacks Consensus Estimate of $3.11 by 1.6%. The bottom-line figure also improved 7.8% from the year-ago quarter’s $2.93 owing to operational improvements.
Lockheed Martin Corp. (LMT - Free Report) reported fourth-quarter 2019 earnings of $5.29 per share, which surpassed the Zacks Consensus Estimate of $4.99 by 6%. The bottom line also improved 20.5% from $4.39 in the year-ago quarter.
Textron Inc. (TXT - Free Report) reported fourth-quarter 2019 adjusted earnings of $1.11 per share, which surpassed the Zacks Consensus Estimate of $1.08 by 2.8%. The bottom line, however, declined 3.5% from $1.15 in the year-ago quarter.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.
This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.
Image: Bigstock
What's in Store for Leidos Holdings (LDOS) in Q4 Earnings?
Leidos Holdings, Inc. (LDOS - Free Report) is scheduled to release fourth-quarter and 2019 results on Feb 18, after market close. In the last reported quarter, the company delivered a positive earnings surprise of 13.33%.
Moreover, Leidos Holdings has a four-quarter positive earnings surprise of 8.93% on average.
Let’s discuss the factors that are likely to get reflected in the upcoming quarterly results.
Factors to Consider
Leidos Holdings generates almost half of its revenues from the Defense Solutions segment. The current U.S. administration is in favor of spending abundantly on the nation’s defense. As a result, steady order growth from Pentagon and other U.S. allies are expected to have boosted defense revenues for the company.
In Health segment, Leidos Holdings completed the acquisition of IMX Medical Management Services and its affiliated businesses in the third quarter. Positive synergies from this buyout are expected to have bolstered the company’s fourth-quarter performance.
Leidos Holdings, Inc. Price and EPS Surprise
Leidos Holdings, Inc. price-eps-surprise | Leidos Holdings, Inc. Quote
Moreover, during the fourth quarter, Leidos Holdings completed the Department of Defense (DoD) Healthcare Management Systems Modernization program (DHMSM), the largest IT transformation in the history of the military health system. Further, the company started deployment of MHS Genesis, a new electronic health record for the Military Health System since Sep 7, 2019.
Such developments must have boosted new program revenues for the company in the yet-to-be-reported quarter. Considering the aforementioned factors, we remain optimistic about Leidos Holdings’ top and bottom line performances in the fourth quarter.
Notably, the Zacks Consensus Estimate for fourth-quarter revenues is pegged at $2.83 billion, which indicates a rise of 6.9% from the year-ago quarter’s reported figure.
Such solid revenue growth along with expected segmental operating margin growth might have boosted the bottom line. The Zacks Consensus Estimate for fourth-quarter earnings per share is pegged at $1.35, which indicates rise of 22.7% from the year-ago quarter’s reported figure.
During the fourth quarter, Leidos Holdings signed a few strategic agreements with the likes of Clarify Health Solutions, D.C. United and Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network. We may expect further details on these deals and their respective impact, if any, once the company releases its numbers on Feb 18.
Earning Whispers
Our proven model does not conclusively predict an earnings beat for Leidos Holdings this earnings season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat.
Earnings ESP: The company’s Earnings ESP is 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Currently, Leidos Holdings carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Recent Defense Releases
Raytheon Company reported fourth-quarter 2019 earnings per share (EPS) of $3.16 from continuing operations, outpacing the Zacks Consensus Estimate of $3.11 by 1.6%. The bottom-line figure also improved 7.8% from the year-ago quarter’s $2.93 owing to operational improvements.
Lockheed Martin Corp. (LMT - Free Report) reported fourth-quarter 2019 earnings of $5.29 per share, which surpassed the Zacks Consensus Estimate of $4.99 by 6%. The bottom line also improved 20.5% from $4.39 in the year-ago quarter.
Textron Inc. (TXT - Free Report) reported fourth-quarter 2019 adjusted earnings of $1.11 per share, which surpassed the Zacks Consensus Estimate of $1.08 by 2.8%. The bottom line, however, declined 3.5% from $1.15 in the year-ago quarter.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.
This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.
See their latest picks free >>